NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
16/11/2024
Voltar para busca
Dado oficial do USPTO
NANOSTRING
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
16/11/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 42
Data de depósito
28/03/2017
Data de registro
07/08/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/11/2024
Última transação
16/11/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
30/08/2017
Primeiro uso no comércio
30/08/2017
Código do desenho
3
Tipo de titular
03
Localização do titular
BILLERICA, MA, US
Examinador
PAPALE,LISA ANNE
Localização atual
Historical data usage
Descrição da marca
The mark consists of the word "nanoString" with a line below the word containing circles.
Titulares e representantes
Titulares
BRUKER SPATIAL BIOLOGY, INC.
NanoString Technologies, Inc.
Representantes
Alyssa Worsham WILSON SONSINI GOODRICH & ROSATI
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagentsslidessolid matrix materialsmicrofluidic devices and support documentationinstructional manualstherefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory usereagents for proteomicsRNA transcription and microRNA expression profilingsmall- molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsclinicaloncologyhematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectorsreagents for scientific or medical research usediagnostic preparations and reagents for scientific or research usesRNA transcription profilingproteomicsclinical diagnosticsenvironmental monitoringbiosurveillanceagricultural inspectionforensic testing of samples containing microorganisms or human fluidssmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing; test kitsconsisting of chemical preparations for scientific purposesin particular for the detectiondiagnosisprogress monitoring and progress prediction of diseasesincluding inflammationsinfectionsdisorders of the central nervous systemscardiovascularneurologicalendocrineautoimmune and genetic disorders and cancers; assaysreagentsenzymespolymerasesbuffers and nucleotideskits comprised thereofall for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors namelydiagnostic reagents for scientific in vitro use in biochemistryclinical chemistry and microbiologyRNA and microRNA expression transcription profilingproteomicsclinical diagnosticsenvironmental monitoringagricultural inspectionsmall- molecule analysissingle nucleotide polymorphisms analysisDNA sequencing
Classe 5
Diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising primarily reagentsslidessolid matrix materialsmicrofluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogenscomprising primarily reagentsslidessolid matrix materialsmicrofluidic devices sold as a unit and instructional manuals therefor; medical diagnostic kits comprising medical diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample typeequipmentmedical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample typesold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type in the nature of equipmentmedical diagnostic immune-assays for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profilingproteomicssmall molecule analysissingle nucleotide polymorphisms analysisDNA sequencingdetection of polymorphisms in human fluidsdetection of copy number variationsclinicaloncologyhematology diagnostics; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care namelymedical diagnostic reagents for RNA and microRNA expression transcription profilingproteomicsclinical diagnosticsenvironmental monitoringagricultural inspectionsmall-molecule analysissingle nucleotide polymorphisms analysisDNA sequencing; tests designed to isolate and extract cells for genetic analysisreagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
Classe 42
Research and product development services for others in the field of biotechnology; medical and scientific research in the field of cancer treatment and diagnosis; providing laboratory research services in the field of gene expression; genetic data mining; providing molecule identification methods for acquiringanalyzing and managing biological and genetic informationin the fields of genetics and environment; research and development services for others in the field of diagnostic compounds for use in medicinemeasuring apparatus for use in product research and developmentseparation and purification processesenvironmental and testing processesindustrial quality control processes; developing systems for acquiringanalyzingmanaging biological and genetic information in the fields of diagnostic reagentsforensicsmedicinegeneticsenvironment; researchdesigndevelopment services for others in the fields of diagnostic reagentscompounds and devicesmeasuring apparatus for use in product research and developmentseparation and purification processesenvironmental and testing processes and industrial quality control processes; chemical screening analysis for others
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
16/11/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/11/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/07/2024
E815
TEAS SECTION 8 & 15 RECEIVED
03/06/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/08/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
18/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/08/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
30/06/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
29/06/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/06/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/06/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
08/06/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/06/2018
IUAF
USE AMENDMENT FILED
04/06/2018
DRRR
DIVISIONAL REQUEST RECEIVED
04/06/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
04/06/2018
EISU
TEAS STATEMENT OF USE RECEIVED
04/06/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/04/2018
EX1G
SOU EXTENSION 1 GRANTED
30/03/2018
EXT1
SOU EXTENSION 1 FILED
30/03/2018
EEXT
SOU TEAS EXTENSION RECEIVED
30/03/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17/10/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/08/2017
PUBO
PUBLISHED FOR OPPOSITION
22/08/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/06/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
22/06/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
22/06/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
22/06/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
22/06/2017
DOCK
ASSIGNED TO EXAMINER
20/06/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/04/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/04/2017
NWAP
NEW APPLICATION ENTERED
31/03/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NANOSTRING ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.